The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 07, 2023
Filed:
Dec. 06, 2018
Applicant:
The University of Sussex, Brighton, GB;
Inventors:
Assignee:
The University of Sussex, Brighton, GB;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/18 (2006.01); A61K 9/00 (2006.01); A61K 9/70 (2006.01); A61K 31/16 (2006.01); A61K 31/225 (2006.01); A61K 31/47 (2006.01); A61K 31/4704 (2006.01); A61K 31/4745 (2006.01); A61K 33/24 (2019.01); A61L 31/16 (2006.01); A61P 17/02 (2006.01); A61K 31/472 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1816 (2013.01); A61K 9/0024 (2013.01); A61K 9/7023 (2013.01); A61K 31/16 (2013.01); A61K 31/225 (2013.01); A61K 31/47 (2013.01); A61K 31/472 (2013.01); A61K 31/4704 (2013.01); A61K 31/4745 (2013.01); A61K 33/24 (2013.01); A61L 31/16 (2013.01); A61P 17/02 (2018.01);
Abstract
The present invention relates to a hypoxia-inducible factor (HIF) activator, or a pharmaceutically acceptable salt or solvate thereof, for use in promoting tissue repair. The HIF activator, or the pharmaceutically acceptable salt or solvate thereof, is for use with a prototypical tissue-protective cytokine, or a pharmaceutically acceptable salt or solvate thereof, which is administered exogenously to the body being treated.